The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.
Official Title: Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.
Study ID: NCT02063113
Brief Summary: The aim of this study is to determine whether the presence of vulnerability detected by geriatricians is associated with treatment discontinuation in older patient. During the comprehensive geriatric assessment realized before the decision-treatment, the following data are recorded and their impact in the therapeutic changes will also be analysed: comorbidity, age, depression, functional status, the cognitive impairment and malnutrition.
Detailed Description:
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
CHD Vendée La Roche sur Yon, La Roche-sur-Yon, , France
CHU de Nantes, Nantes, , France
Name: Komivi AGBETSIVI, DR
Affiliation: CHD Vendée La Roche sur Yon
Role: PRINCIPAL_INVESTIGATOR
Name: VIGNARD Patricia, Dr
Affiliation: CH du Mans
Role: PRINCIPAL_INVESTIGATOR
Name: Catherine Cattenoz, Dr
Affiliation: Rennes University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jean -Richard EVEILLARD, Dr
Affiliation: CHU de Brest
Role: PRINCIPAL_INVESTIGATOR
Name: François Puisieux, Pr
Affiliation: CHU de Lille
Role: PRINCIPAL_INVESTIGATOR
Name: Jean -Yves NIEMIER, Dr
Affiliation: CHU de Nancy
Role: PRINCIPAL_INVESTIGATOR
Name: Frédérique Retornaz, Dr
Affiliation: CGD de Marseille
Role: PRINCIPAL_INVESTIGATOR
Name: Véronique Brunel, Dr
Affiliation: Hôpital Européen de Marseille
Role: PRINCIPAL_INVESTIGATOR
Name: Laure De Decker, Dr
Affiliation: Nantes University Hospital
Role: PRINCIPAL_INVESTIGATOR